IBOV 176,491 ▲ 2.17% IPSA 10,989 ▼ 0.33% IPC MEX 66,689 ▲ 0.88% MERVAL 3,228,336 ▲ 0.81% COLCAP 2,287.31 ▼ 0.24% BVL PERÚ 56,194.27 ▲ 1.22% USD/BRL5.10▼ 0.25% USD/MXN17.50▼ 0.28% USD/CLP923.93▼ 0.41% USD/COP3,231▼ 3.34% USD/PEN3.39▼ 0.29% USD/ARS1,487▼ 0.03% USD/UYU40.22▲ 1.20% USD/PYG6,055▲ 1.53% USD/BOB10.14▲ 4.01% USD/DOP58.48▼ 0.12% USD/CRC448.82▲ 1.40% USD/GTQ7.63▲ 2.28% USD/HNL26.72▲ 1.50% USD/NIO36.62▲ 0.26% USD/VES707.92▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD158.09▲ 0.81% USD/TTD6.75▲ 1.32% EUR/BRL5.83▼ 0.99% BRENT 76.09 ▼ 0.28% WTI 71.55 ▼ 0.74% IRON ORE 161.91 — — COPPER 6.27 ▲ 0.88% GOLD 4,108 ▼ 0.54% SILVER 59.99 ▼ 0.64% SOY 1,189 ▲ 0.74% CORN 456.75 ▲ 6.78% WHEAT 646.25 ▲ 5.73% COFFEE 327.75 ▼ 8.18% SUGAR 14.84 ▼ 1.85% ORANGE JUICE 147.20 ▼ 1.80% COTTON 80.08 ▲ 5.15% COCOA 6,094 ▼ 3.41% BEEF 229.60 ▼ 2.40% CATTLE 352.65 ▼ 0.98% LITHIUM 72.09 ▼ 1.00% PETR4 39.61 ▲ 1.02% VALE3 74.07 ▲ 1.26% ITUB4 43.80 ▲ 2.84% BBDC4 18.57 ▲ 3.17% ABEV3 15.87 ▲ 0.95% BBAS3 20.37 ▲ 1.85% B3SA3 15.35 ▲ 3.79% WEGE3 46.43 ▲ 1.51% PRIO3 55.51 ▼ 0.18% SUZB3 41.61 ▲ 1.41% RENT3 40.56 ▲ 2.94% AZZA3 18.94 ▲ 2.60% CSAN3 3.98 ▲ 3.11% RAIZ4 0.37 — 0.00% PCAR3 2.78 ▲ 0.72% GMAT3 4.01 ▲ 2.04% PSSA3 54.19 ▲ 1.57% CVCB3 1.26 ▲ 0.80% POSI3 3.96 ▲ 2.86% SLCE3 13.90 ▲ 0.80% NATU3 8.59 ▲ 1.54% BRKM5 6.42 ▲ 0.94% RANI3 7.98 ▲ 1.53% CSNA3 5.06 ▲ 5.42% CMIN3 5.09 ▲ 5.38% USIM5 8.40 ▲ 0.60% GGBR4 23.01 ▲ 2.36% ENEV3 26.83 ▲ 2.40% CPFE3 47.22 ▲ 2.01% CMIG4 11.31 ▲ 2.08% EQTL3 40.54 ▲ 2.61% LREN3 14.68 ▲ 3.75% VIVT3 35.50 ▲ 2.90% RAIL3 13.92 ▲ 1.24% KLABIN 17.55 ▲ 0.86% RAIA DROGASIL 18.71 ▲ 3.20% RDOR3 36.11 ▲ 2.73% HAPV3 10.46 ▲ 3.87% FLRY3 16.28 ▲ 3.37% SMTO3 15.99 ▼ 0.37% UGPA3 30.57 ▲ 1.56% VBBR3 32.78 ▲ 2.12% BBSE3 39.81 ▲ 1.35% BPAC11 57.12 ▲ 2.59% CURY3 33.87 ▲ 3.58% AERI3 2.08 ▲ 0.97% VIVARA 22.91 ▲ 1.46% COMPASS 25.01 ▲ 1.34% VAMOS 3.03 ▲ 2.36% SANB11 27.17 ▲ 3.50% ASAI3 8.81 ▲ 4.14% SBSP3 30.97 ▲ 3.23% WALMEX 49.44 ▲ 0.86% GMEXICO 196.28 ▲ 0.48% FEMSA 224.10 ▲ 0.78% CEMEX 22.11 ▲ 1.84% GFNORTE 188.44 ▲ 1.67% BIMBO 56.23 ▲ 0.54% TELEVISA 9.61 ▲ 1.26% AMX 23.04 ▲ 1.77% GAP 412.74 ▼ 0.24% ASUR 284.26 ▲ 0.23% OMA 238.17 ▲ 0.07% KOF 183.04 ▲ 1.18% GRUMA 285.78 ▲ 1.24% KIMBER 38.33 ▼ 0.29% SQM-B 67,500 ▼ 2.32% COPEC 6,005 ▼ 0.25% BSANTANDER 78.19 ▲ 0.89% FALABELLA 5,881 ▲ 0.52% ENELAM 84.70 ▲ 0.64% CENCOSUD 2,060 ▲ 0.17% CMPC 1,118 ▲ 2.15% BANCO CHILE 188.16 ▲ 0.62% LATAM AIR 26.27 ▼ 0.49% YPF 74,150 ▼ 2.14% GGAL 8,090 ▲ 2.67% PAMPA 5,170 ▼ 0.67% TXAR 661.00 ▼ 0.53% ALUAR 971.00 ▲ 0.26% TGS 9,515 ▲ 2.20% CEPU 2,315 — 0.00% MIRGOR 17,050 ▼ 0.87% COME 45.35 ▼ 0.15% LOMA NEGRA 3,500 ▲ 0.07% BYMA 310.00 ▲ 0.08% TELECOM ARG 4,190 ▲ 1.70% ECOPETROL 15.37 ▼ 0.13% BANCOLOMBIA 82.72 ▲ 2.21% GRUPO AVAL 5.08 ▲ 1.20% CREDICORP 398.88 ▲ 1.78% SOUTHERN COPPER 175.34 ▲ 0.52% BUENAVENTURA 30.05 ▲ 1.69% MERCADOLIBRE 1,856 ▲ 2.64% NUBANK 13.89 ▲ 1.57% XP 16.93 ▲ 3.14% PAGSEGURO 9.30 ▲ 3.28% STONE 11.16 ▲ 1.78% GLOBANT 30.69 ▼ 1.92% TECNOGLASS 44.12 ▲ 2.27% GAP AIRPORT 235.43 ▲ 0.41% ASUR 284.26 ▲ 0.23% OMA AIRPORT 108.63 ▲ 0.28% AMX ADR 26.27 ▲ 1.66% FEMSA ADR 128.25 ▲ 0.98% CEMEX ADR 12.67 ▲ 2.38% PETROBRAS ADR 17.19 ▲ 0.91% VALE ADR 14.46 ▲ 1.65% ITAU ADR 8.56 ▲ 3.38% SANTANDER BR 5.37 ▲ 4.47% AMBEV ADR 3.08 ▲ 1.15% CSN 1.00 ▲ 4.52% GERDAU 4.52 ▲ 2.38% LATAM ADR 56.77 ▼ 0.48% BTC 64,019 ▲ 1.31% ETH 1,790 ▲ 2.58% SOL 77.97 ▼ 0.10% XRP 1.10 ▲ 0.81% BNB 573.00 ▲ 0.80% ADA 0.17 ▼ 0.31% DOGE 0.07 ▲ 1.44% AVAX 6.71 ▲ 0.41% LINK 7.91 ▲ 2.35% DOT 0.87 ▲ 5.81% LTC 44.56 ▲ 1.82% BCH 249.64 ▲ 4.99% TRX 0.33 ▼ 0.46% XLM 0.19 ▲ 1.40% HBAR 0.07 ▲ 0.23% NEAR 1.90 ▼ 1.27% ATOM 1.57 ▲ 1.49% AAVE 95.04 ▲ 4.15% SELIC 14.25% EMBRAER 84.81 ▲ 1.13% EMBRAER ADR 66.35 ▲ 1.24% JBS 11.90 ▲ 1.45% JBS BDR 60.80 ▲ 1.25% MBRF3 15.80 ▲ 2.53% MBRFY 3.03 ▲ 1.00% INTER 5.86 ▲ 2.54% IBOV 176,491 ▲ 2.17% IPSA 10,989 ▼ 0.33% IPC MEX 66,689 ▲ 0.88% MERVAL 3,228,336 ▲ 0.81% COLCAP 2,287.31 ▼ 0.24% BVL PERÚ 56,194.27 ▲ 1.22% USD/BRL 5.10 ▼ 0.24% USD/MXN 17.50 ▼ 0.28% USD/CLP 923.93 ▼ 0.41% USD/COP 3,231 ▼ 3.34% USD/PEN 3.39 ▼ 0.20% USD/ARS 1,487 ▼ 0.03% USD/UYU 40.22 ▲ 1.20% USD/PYG 6,055 ▲ 1.53% USD/BOB 10.14 ▲ 4.01% USD/DOP 58.48 ▼ 0.12% USD/CRC 448.82 ▲ 1.40% USD/GTQ 7.63 ▲ 2.28% USD/HNL 26.72 ▲ 1.50% USD/NIO 36.62 ▲ 0.26% USD/VES 707.92 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 158.09 ▲ 0.81% USD/TTD 6.75 ▲ 1.32% EUR/BRL 5.83 ▼ 0.99% BRENT 76.09 ▼ 0.28% WTI 71.55 ▼ 0.74% IRON ORE 161.91 — — COPPER 6.27 ▲ 0.88% GOLD 4,108 ▼ 0.54% SILVER 59.99 ▼ 0.64% SOY 1,189 ▲ 0.74% CORN 456.75 ▲ 6.78% WHEAT 646.25 ▲ 5.73% COFFEE 327.75 ▼ 8.18% SUGAR 14.84 ▼ 1.85% ORANGE JUICE 147.20 ▼ 1.80% COTTON 80.08 ▲ 5.15% COCOA 6,094 ▼ 3.41% BEEF 229.60 ▼ 2.40% CATTLE 352.65 ▼ 0.98% LITHIUM 72.09 ▼ 1.00% PETR4 39.61 ▲ 1.02% VALE3 74.07 ▲ 1.26% ITUB4 43.80 ▲ 2.84% BBDC4 18.57 ▲ 3.17% ABEV3 15.87 ▲ 0.95% BBAS3 20.37 ▲ 1.85% B3SA3 15.35 ▲ 3.79% WEGE3 46.43 ▲ 1.51% PRIO3 55.51 ▼ 0.18% SUZB3 41.61 ▲ 1.41% RENT3 40.56 ▲ 2.94% AZZA3 18.94 ▲ 2.60% CSAN3 3.98 ▲ 3.11% RAIZ4 0.37 — 0.00% PCAR3 2.78 ▲ 0.72% GMAT3 4.01 ▲ 2.04% PSSA3 54.19 ▲ 1.57% CVCB3 1.26 ▲ 0.80% POSI3 3.96 ▲ 2.86% SLCE3 13.90 ▲ 0.80% NATU3 8.59 ▲ 1.54% BRKM5 6.42 ▲ 0.94% RANI3 7.98 ▲ 1.53% CSNA3 5.06 ▲ 5.42% CMIN3 5.09 ▲ 5.38% USIM5 8.40 ▲ 0.60% GGBR4 23.01 ▲ 2.36% ENEV3 26.83 ▲ 2.40% CPFE3 47.22 ▲ 2.01% CMIG4 11.31 ▲ 2.08% EQTL3 40.54 ▲ 2.61% LREN3 14.68 ▲ 3.75% VIVT3 35.50 ▲ 2.90% RAIL3 13.92 ▲ 1.24% KLABIN 17.55 ▲ 0.86% RAIA DROGASIL 18.71 ▲ 3.20% RDOR3 36.11 ▲ 2.73% HAPV3 10.46 ▲ 3.87% FLRY3 16.28 ▲ 3.37% SMTO3 15.99 ▼ 0.37% UGPA3 30.57 ▲ 1.56% VBBR3 32.78 ▲ 2.12% BBSE3 39.81 ▲ 1.35% BPAC11 57.12 ▲ 2.59% CURY3 33.87 ▲ 3.58% AERI3 2.08 ▲ 0.97% VIVARA 22.91 ▲ 1.46% COMPASS 25.01 ▲ 1.34% VAMOS 3.03 ▲ 2.36% SANB11 27.17 ▲ 3.50% ASAI3 8.81 ▲ 4.14% SBSP3 30.97 ▲ 3.23% WALMEX 49.44 ▲ 0.86% GMEXICO 196.28 ▲ 0.48% FEMSA 224.10 ▲ 0.78% CEMEX 22.11 ▲ 1.84% GFNORTE 188.44 ▲ 1.67% BIMBO 56.23 ▲ 0.54% TELEVISA 9.61 ▲ 1.26% AMX 23.04 ▲ 1.77% GAP 412.74 ▼ 0.24% ASUR 284.26 ▲ 0.23% OMA 238.17 ▲ 0.07% KOF 183.04 ▲ 1.18% GRUMA 285.78 ▲ 1.24% KIMBER 38.33 ▼ 0.29% SQM-B 67,500 ▼ 2.32% COPEC 6,005 ▼ 0.25% BSANTANDER 78.19 ▲ 0.89% FALABELLA 5,881 ▲ 0.52% ENELAM 84.70 ▲ 0.64% CENCOSUD 2,060 ▲ 0.17% CMPC 1,118 ▲ 2.15% BANCO CHILE 188.16 ▲ 0.62% LATAM AIR 26.27 ▼ 0.49% YPF 74,150 ▼ 2.14% GGAL 8,090 ▲ 2.67% PAMPA 5,170 ▼ 0.67% TXAR 661.00 ▼ 0.53% ALUAR 971.00 ▲ 0.26% TGS 9,515 ▲ 2.20% CEPU 2,315 — 0.00% MIRGOR 17,050 ▼ 0.87% COME 45.35 ▼ 0.15% LOMA NEGRA 3,500 ▲ 0.07% BYMA 310.00 ▲ 0.08% TELECOM ARG 4,190 ▲ 1.70% ECOPETROL 15.37 ▼ 0.13% BANCOLOMBIA 82.72 ▲ 2.21% GRUPO AVAL 5.08 ▲ 1.20% CREDICORP 398.88 ▲ 1.78% SOUTHERN COPPER 175.34 ▲ 0.52% BUENAVENTURA 30.05 ▲ 1.69% MERCADOLIBRE 1,856 ▲ 2.64% NUBANK 13.89 ▲ 1.57% XP 16.93 ▲ 3.14% PAGSEGURO 9.30 ▲ 3.28% STONE 11.16 ▲ 1.78% GLOBANT 30.69 ▼ 1.92% TECNOGLASS 44.12 ▲ 2.27% GAP AIRPORT 235.43 ▲ 0.41% ASUR 284.26 ▲ 0.23% OMA AIRPORT 108.63 ▲ 0.28% AMX ADR 26.27 ▲ 1.66% FEMSA ADR 128.25 ▲ 0.98% CEMEX ADR 12.67 ▲ 2.38% PETROBRAS ADR 17.19 ▲ 0.91% VALE ADR 14.46 ▲ 1.65% ITAU ADR 8.56 ▲ 3.38% SANTANDER BR 5.37 ▲ 4.47% AMBEV ADR 3.08 ▲ 1.15% CSN 1.00 ▲ 4.52% GERDAU 4.52 ▲ 2.38% LATAM ADR 56.77 ▼ 0.48% BTC 64,019 ▲ 1.31% ETH 1,790 ▲ 2.58% SOL 77.97 ▼ 0.10% XRP 1.10 ▲ 0.81% BNB 573.00 ▲ 0.80% ADA 0.17 ▼ 0.31% DOGE 0.07 ▲ 1.44% AVAX 6.71 ▲ 0.41% LINK 7.91 ▲ 2.35% DOT 0.87 ▲ 5.81% LTC 44.56 ▲ 1.82% BCH 249.64 ▲ 4.99% TRX 0.33 ▼ 0.46% XLM 0.19 ▲ 1.40% HBAR 0.07 ▲ 0.23% NEAR 1.90 ▼ 1.27% ATOM 1.57 ▲ 1.49% AAVE 95.04 ▲ 4.15% SELIC 14.25% EMBRAER 84.81 ▲ 1.13% EMBRAER ADR 66.35 ▲ 1.24% JBS 11.90 ▲ 1.45% JBS BDR 60.80 ▲ 1.25% MBRF3 15.80 ▲ 2.53% MBRFY 3.03 ▲ 1.00% INTER 5.86 ▲ 2.54%
since 2009
Friday, July 10, 2026

Covid-19 vaccines cause myocarditis in youngsters, says study

By · May 13, 2023 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

By Luís Batistela

The vaccines from Pfizer and Moderna are causing myocarditis in young people between 13 and 21 years old, as shown in an American study conducted at Yale University in New Haven (CT).

One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

The research was published in the journal Science Immunology. According to the researchers, this situation occurs due to an immune system’s overreaction motivated by vaccines.

Myocarditis is inflammation of the myocardium, i.e., the thick layer – located between the epicardium and endocardium – responsible for constituting one of the “walls” of the heart.

(Jordon Trishton Walker, Pfizer’s Director of Research and Development, recoreded with a hidden camera reported that the company is operating on the mutation of the coronavirus to achieve commercial advantages in anticipation of manufacturing the vaccines.)

The scientists concluded that the myocarditis is being caused by an over-reaction of the immune system and inflammatory cells in response to the application of the Pfizer and Moderna vaccines:

“The immune system of these individuals gets a little too fast and overproduces cytokines and cellular responses,” clarified research corps leader Carrie Lucas.

The group took blood samples from 23 patients between the ages of 13 and 21 – 87% of whom were men – who developed myocarditis after the second dose of the vaccines.

In such patients, they found an exacerbated amount of cytokines and white blood cells, molecules that induce the body’s reaction, attacking the very physical structure of the sick.

Despite finding the relationship between myocarditis and Covid-19 vaccines, the author of the Yale paper, Anis Barmada, intends to use the research to optimize the “immunizers” to operate them against the coronavirus.

PFIZER SCANDALS

Recorded with a hidden camera, the executive also explained how Big Pharma controls the regulatory agencies of the American government.

Jordon Trishton Walker, Pfizer’s Director of Research and Development, reported that the company is operating on the mutation of the coronavirus to achieve commercial advantages in anticipation of manufacturing the vaccines.

“You have to be very controlled to ensure that this virus you mutate doesn’t create something that goes everywhere. Which, I suspect, is the way the virus started in Wuhan, to be honest.”

“It doesn’t make sense that this virus came out of nowhere. It’s nonsense […] You shouldn’t do gain-of-function research with viruses. Not on a regular basis.”

“We can make these selected structure mutations to make them more potent. I don’t know how that will work. There is research going on about that. There better not be any more outbreaks because… Jesus Christ,” Walker said.

On another occasion, Pfizer CEO Albert Bourla was silent before Rabel News reporters when asked about the ineffectiveness of the vaccines, as well as the risks posed by the “immunizer.”

Reporters Ezra Levant and Avi Yemini asked Bourla about the transmission of the virus among vaccinees.

The journalists also demanded the CEO apologize for the lies he had spread to promote Pfizer.

In August 2022, Bourla contracted Covid-19 after taking four doses of his company’s vaccine.

The CEO did not comment on the ineffectiveness of the “immunizer”; even then, he promoted Paxlovid – a medicine produced by Big Pharma, which also did not show success in the fight against the coronavirus.

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.